West Pharmaceutical Services Inc.
WST | NYSE
$414.48
+$1.86 (+0.45%)
Nov 2, 2026, 10:41 AM ET · Market open
Fiscal Quarter Period Ending | Q3 2026 Sep 30, 2026 | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 | Q2 2025 Jun 30, 2025 | Q1 2025 Mar 31, 2025 | Q4 2024 Dec 31, 2024 | Q3 2024 Sep 30, 2024 | Q2 2024 Jun 30, 2024 | Q1 2024 Mar 31, 2024 | Q4 2023 Dec 31, 2023 | Q3 2023 Sep 30, 2023 | Q2 2023 Jun 30, 2023 | Q1 2023 Mar 31, 2023 | Q4 2022 Dec 31, 2022 | Q3 2022 Sep 30, 2022 | Q2 2022 Jun 30, 2022 | Q1 2022 Mar 31, 2022 | Q4 2021 Dec 31, 2021 | Q3 2021 Sep 30, 2021 | Q2 2021 Jun 30, 2021 | Q1 2021 Mar 31, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | 214M | 154M | 138.8M | 132.1M | 140M | 131.8M | 89.8M | 130.1M | 136M | 111.3M | 115.3M | 137M | 161.3M | 155.1M | 140M | 103M | 120.6M | 188.5M | 173.8M | 147.7M | 175.6M | 187.3M | 151.2M |
Depreciation & Amortization | 45.9M | 46.2M | 44.6M | 47M | 43M | 41.4M | 40M | 40.7M | 40.2M | 38.9M | 35.6M | 35.9M | 35.7M | 34.1M | 31.6M | 31.1M | 29.8M | 30.1M | 29.6M | 34.4M | 30M | 28.8M | 29.1M |
Stock-Based Compensation | 4.3M | 10.9M | 6.6M | 6.7M | 8.4M | 7.4M | 1.3M | 4.3M | 5.1M | 4.3M | 5M | 1.4M | 5.9M | 7.5M | 8.5M | 6.7M | 6M | 5.5M | 5.5M | 10M | 11.3M | 10.3M | 5.9M |
Other Working Capital | -19.3M | 102.9M | -102.9M | 119.7M | 2.1M | -100K | 100K | 23.5M | -100K | 14.1M | -34.6M | 26.9M | 24.8M | -25.3M | -46.8M | 206M | -31.6M | -47.5M | -50.2M | -5.3M | -20M | -73.6M | -94.9M |
Other Non-Cash Items | -55.4M | -190M | 2.8M | 1.5M | 3.7M | -3.4M | -1.8M | -8.5M | -1.1M | -3.6M | -3.1M | 14.5M | 194.4M | -5.9M | 4.8M | 3M | 44.1M | -3.5M | -7.5M | 17.1M | -6.8M | -8.5M | -3.2M |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 23.4M | -192M | 3.7M | n/a | -30.8M | n/a | n/a | n/a | -43.1M | n/a | 100K | 600K |
Change in Working Capital | -19.3M | 102.9M | -102.9M | 63.8M | 2.1M | -100K | 100K | 23.5M | -100K | 14.1M | -34.6M | 26.9M | 24.8M | -25.3M | -46.8M | 117.8M | -31.6M | -47.5M | -50.2M | -5.3M | -20M | -73.6M | -94.9M |
Operating Cash Flow | 189.5M | 124M | 89.9M | 251.1M | 197.2M | 177.1M | 129.4M | 190.1M | 180.1M | 165M | 118.2M | 239.1M | 230.1M | 169.2M | 138.1M | 230.8M | 168.9M | 173.1M | 151.2M | 160.8M | 190.1M | 144.4M | 88.7M |
Capital Expenditures | -39.1M | -43.2M | -42.7M | -76.1M | -63.3M | -75.2M | -71.3M | -104.9M | -81.3M | -100.2M | -90.6M | -108.7M | -95.8M | -75.4M | -82.1M | -94.9M | -57.8M | -66.1M | -65.8M | -76.5M | -65.3M | -56.9M | -54.7M |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -2.2M | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | 118M | n/a | n/a | n/a | n/a | n/a | n/a | 100K | -800K | -1M | n/a | -100K | 100K | -6.7M | n/a | 100K | -1.3M | 100K | -2.5M | 1.3M | n/a | 1M | 200K |
Investing Cash Flow | 78.9M | -43.2M | -42.7M | -76.1M | -63.3M | -75.2M | -71.3M | -104.8M | -82.1M | -101.2M | -90.6M | -108.8M | -95.7M | -82.1M | -82.1M | -94.8M | -59.1M | -66M | -68.3M | -77.4M | -65.3M | -55.9M | -54.5M |
Debt Repayment | -500K | -400K | -300K | -300K | -300K | -300K | -200K | -100K | -3.5M | -23.4M | -600K | -600K | -600K | -500K | -600K | -600K | -42.6M | -500K | -600K | -1.1M | n/a | -500K | -600K |
Common Stock Repurchased | -231M | 297.6M | -297.6M | -200K | -100K | -500K | -136M | -54.6M | -52.4M | -187.2M | -272.4M | -177.1M | -28.1M | -174.4M | -71.6M | 100K | -27.5M | -28.9M | -165.9M | -100K | -300K | -700K | -150.8M |
Dividend Paid | -15.5M | -15.7M | -15.8M | -15.8M | -15.1M | -15.1M | -15.2M | -15.3M | -14.5M | -14.6M | -14.7M | -14.8M | -14M | -14.1M | -14.1M | -14.1M | -13.5M | -13.1M | -13.4M | -13.3M | -12.6M | -12.6M | -12.6M |
Other Financial Acitivies | -1.3M | -438.8M | -2.5M | 4.6M | n/a | 1M | 4.4M | 1.1M | 6M | 6.9M | 16.7M | 3M | 20.4M | 12.2M | 15.3M | 5.1M | 8.4M | 6.3M | 7.2M | 8.3M | 7.1M | 14.1M | 7.6M |
Financial Cash Flow | -241.8M | -164.8M | -308.7M | -11.7M | -11.5M | -14.9M | -147M | -68.9M | -64.4M | -218.3M | -271M | -189.5M | -22.3M | -176.8M | -71M | -9.5M | -75.2M | -36.2M | -172.7M | -6.2M | -5.8M | 300K | -156.4M |
Net Cash Flow | 28.3M | -85.6M | -269.9M | 162.8M | 118.8M | 105.5M | -80.4M | -6.3M | 44.7M | -155.6M | -252.1M | -44.7M | 102.3M | -90M | -8M | 165.3M | 10.5M | 50.8M | -94.9M | 74.6M | 111.8M | 92.5M | -131.8M |
Free Cash Flow | 150.4M | 80.8M | 47.2M | 175M | 133.9M | 101.9M | 58.1M | 85.2M | 98.8M | 64.8M | 27.6M | 130.4M | 134.3M | 93.8M | 56M | 135.9M | 111.1M | 107M | 85.4M | 84.3M | 124.8M | 87.5M | 34M |
Adj. Free Cash Flow | 146.1M | 69.9M | 40.6M | 168.3M | 125.5M | 94.5M | 56.8M | 80.9M | 93.7M | 60.5M | 22.6M | 129M | 128.4M | 86.3M | 47.5M | 129.2M | 105.1M | 101.5M | 79.9M | 74.3M | 113.5M | 77.2M | 28.1M |
Maintenance CapEx | -39.1M | -43.2M | -42.7M | -47.73M | -34.48M | -42.96M | -69.84M | -96.99M | -81.3M | -100.2M | -90.6M | -97.57M | -67.12M | -75.4M | -82.1M | -94.9M | -57.8M | -43.99M | -43.13M | -5.56M | n/a | n/a | n/a |
Growth CapEx | n/a | n/a | n/a | -28.37M | -28.82M | -32.24M | -1.46M | -7.91M | n/a | n/a | n/a | -11.13M | -28.68M | n/a | n/a | n/a | n/a | -22.11M | -22.67M | -70.94M | -65.3M | -56.9M | -54.7M |
Owner Earnings | 150.4M | 80.8M | 47.2M | 203.37M | 162.72M | 134.14M | 59.56M | 93.11M | 98.8M | 64.8M | 27.6M | 141.53M | 162.98M | 93.8M | 56M | 135.9M | 111.1M | 129.11M | 108.07M | 155.24M | 190.1M | 144.4M | 88.7M |
Add to Watchlist
Select watchlists to add or remove WST